Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test boosts lung cancer screening rates in High-Risk patients

NCT ID NCT06145750

First seen Nov 24, 2025 · Last updated May 24, 2026 · Updated 21 times

Summary

This study looked at whether giving doctors access to a simple blood test called FirstLook™ would encourage more people at high risk for lung cancer to get screened. The study involved 28 medical practices and their patients who were eligible for lung cancer screening but had not done it yet. The goal was to see if the blood test option increased overall screening rates compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • DARTNet Institute

    Aurora, Colorado, 80045, United States

  • Duke University

    Durham, North Carolina, 27705, United States

  • University Of Florida

    Jacksonville, Florida, 32209, United States

Conditions

Explore the condition pages connected to this study.